Novo Nordisk | NVO - Capitale Ordinario





Capitale Ordinario Cambiamento Data
ANI Pharmaceuticals USD 22.49M 760K 2025-12
Aurora Cannabis CAD 56.71M 134.13K 2025-12
Bausch Health Companies USD 373.46M 2.93M 2026-03
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
Canopy Growth CAD 368.28M 35.9M 2025-12
Corcept Therapeutics USD 107.33M 1.36M 2026-03
Drreddys Laboratories INR 832.57M 53K 2025-12
Eli Lilly USD 943.5M 3.33M 2026-03
GlaxoSmithKline GBP 4.05B 20.6M 2026-03
Merck USD 2.47B 12.72M 2025-12
Nektar Therapeutics USD 20.38M 20.36M 2025-12
Novartis USD 1.91B 60K 2026-03
Novo Nordisk DKK 4.44B 0 2025-12
Novo Nordisk DKK 4.44B 3.99B 2025-06
Pacira USD 39.31M 1.81M 2026-03
Perrigo USD 138.1M 500K 2026-03
Phibro Animal Health USD 40.48M 0 2025-12
Prestige Brands USD 47.32M 765K 2025-12
Sanofi EUR 1.21B 8.25M 2026-03
Supernus Pharmaceuticals USD 58.04M 582K 2026-03
Zoetis USD 420.35M 4.58M 2026-03